Case report: Real-world experience using a personalized cancer-specific circulating tumor DNA assay in different metastatic melanoma scenarios

Circulating-tumor DNA (ctDNA) has emerged as an important biomarker for monitoring disease status in cancer patients. Different ctDNA testing platforms have shown promising results in the early detection of disease, monitoring response to treatment, and prognostication in metastatic melanoma. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Khaddour, Karam, Zhou, Alice, Butt, Omar H., Budde, Griffin, Malashevich, Allyson Koyen, Ansstas, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713015/
https://www.ncbi.nlm.nih.gov/pubmed/36465349
http://dx.doi.org/10.3389/fonc.2022.978996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713015/
https://www.ncbi.nlm.nih.gov/pubmed/36465349
http://dx.doi.org/10.3389/fonc.2022.978996

Ejemplares similares